
New real-world data in obese, antidepressant-naive patients with MDD shows bupropion edging SSRIs on remission, though rates stay low.
Dr Khorassani is a health sciences associate clinical professor at the University of California, Irvine School of Pharmacy and Pharmaceutical Sciences.

New real-world data in obese, antidepressant-naive patients with MDD shows bupropion edging SSRIs on remission, though rates stay low.